Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children
Authors:
- Kazeem AkanoKAKazeem Akano
- Godwin NtadomGNGodwin Ntadom
- Chimere AgomoCAChimere Agomo
- Christian T. HappiCHChristian T. Happi
- Onikepe A. FolarinOFOnikepe A. Folarin
- Grace O. GbotoshoGGGrace O. Gbotosho
- Olugbenga MokuoluOMOlugbenga Mokuolu
- Finomo FinomoFFFinomo Finomo
- Joy C. EbenebeJEJoy C. Ebenebe
- Nma JiyaNJNma Jiya
- Jose AmbeJAJose Ambe
- Robinson WammandaRWRobinson Wammanda
Open Access
- 7 December 2018
- journal article
- research article
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 7 (1) , 122
Abstract
In acute falciparum malaria, asexual parasite reduction ratio two days post-treatment initiation (PRRD2) ≥ 10 000 per cycle has been used as a measure of the rapid clearance of parasitaemia and efficacy of artemisinin derivatives. However, there is little evaluation of alternative measures; for example, parasite reduction ratio one day after treatment initiation (PRRD1) and its relationship with parasite clearance time (PCT) or PRRD2. This study evaluated the use of PRRD1 as a measure of responsiveness to antimalarial drugs. In acutely malarious children treated with artesunate-amodiaquine (AA), artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DHP), the relationships between PRRD1 or PRRD2 and PCT, and between PRRD1 and PRRD2 were evaluated using linear regression. Agreement between estimates of PCT using PRRD1 and PRRD2 linear regression equations was evaluated using the Bland-Altman analysis. Predictors of PRRD1 > 5000 per half cycle and PRRD2 ≥ 10 000 per cycle were evaluated using stepwise multiple logistic regression models. Using the linear regression equation of the relationship between PRRD1 and PCT previously generated in half of the DHP-treated children during the early study phase, PCT estimates were compared in a prospective blinded manner with PCTs determined by microscopy during the later study phase in the remaining half. In 919 malarious children, PRRD1 was significantly higher in DHP- and AA-treated compared with AL-treated children (P < 0.0001). PRRD1 or PRRD2 values correlated significantly negatively with PCT values (P < 0.0001 for each) and significantly positively with each other (P < 0.0001). PCT estimates from linear regression equations for PRRD1 and PRRD2 showed insignificant bias on the Bland-Altman plot (P = 0.7) indicating the estimates can be used interchangeably. At presentation, age > 15 months, parasitaemia > 10 000/μl and DHP treatment independently predicted PRRD1 > 5000 per half cycle, while age > 30 months, haematocrit ≥31%, body temperature > 37.4 °C, parasitaemia > 100 000/μl, PRRD1 value > 1000 and no gametocytaemia independently predicted PRRD2 ≥ 10 000 per cycle. Using the linear regression equation generated during the early phase in 166 DHP-treated children, PCT estimates and PCTs determined by microscopy in the 155 children in the later phase were similar in the same patients. PRRD1 and estimates of PCT using PRRD1 linear regression equation of PRRD1 and PCT can be used in therapeutic efficacy studies. Pan African Clinical Trial Registration PACTR201709002064150, 1 March 2017, http://www.pactr.orgKeywords
This publication has 21 references indexed in Scilit:
- Declining Efficacy of Artemisinin Combination Therapy AgainstP. FalciparumMalaria on the Thai–Myanmar Border (2003–2013): The Role of Parasite Genetic FactorsClinical Infectious Diseases, 2016
- Clinical illness and outcomes in Nigerian children with late-appearing anaemia after artemisinin-based combination treatments of uncomplicated falciparum malariaBMC Infectious Diseases, 2016
- Severe MalariaTropical Medicine & International Health, 2014
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan CoastPLOS ONE, 2011
- Therapeutic Efficacies of Artemisinin-Based Combination Therapies in Nigerian Children with Uncomplicated Falciparum Malaria during Five Years of Adoption as First-Line TreatmentsThe American Journal of Tropical Medicine and Hygiene, 2011
- In Vivo Parasitological Measures of Artemisinin SusceptibilityThe Journal of Infectious Diseases, 2010
- Severe falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Clinical trials of artemisinin and its derivatives in the treatment of malaria in ChinaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986